News

Moderate THST linked to improved survival in thyroid cancer


 

AT THE ATA ANNUAL MEETING

References

The registry has received support from Genzyme and Pfizer. Dr. Carhill reported having no financial disclosures.

dbrunk@frontlinemedcom.com

On Twitter @dougbrunk

Pages

Recommended Reading

Stereotactic laser ablation found feasible for hypothalamic hamartoma
MDedge Family Medicine
Pituitary tumor size not definitive for Cushing's
MDedge Family Medicine
Prolactin measure didn’t help localize pituitary adenoma
MDedge Family Medicine